Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions

v3.21.2
Related Party Transactions
6 Months Ended
Jun. 30, 2021
Related Party Transactions [Abstract]  
Related Party Transactions Related Party TransactionsDuring the three and six months ended June 30, 2021 and 2020, our joint venture in China, owned 80% percent by us and 20% percent by a wholly owned subsidiary of Fosun Pharma, did not borrow any amounts from the Company or our joint venture partner. As of June 30, 2021 and December 31, 2020 outstanding borrowings by NSP China from the Company were $3.7 million and $4.8 million, respectively. As of June 30, 2021 and December 31, 2020 outstanding borrowings by NSP China from our joint venture partner were $0.9 million and $1.2 million, respectively. These notes are payable in less than one year and bear interest of 3.0 percent. The notes between NSP China and the Company eliminate in consolidation.